Primary Care Diabetes
Volume 1, Issue 4 , Pages 187-193 , December 2007

Cognitive dysfunction and diabetes: Implications for primary care

  • Geert Jan Biessels

      Affiliations

    • Department of Neurology, Rudolf Magnus Institute of Neurosciences, University Medical Center Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author at: Department of Neurology G03.228, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands. Tel.: +31 30 2508600; fax: +31 30 2542100.
    • ,
  • Anneloes Kerssen

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
    • ,
  • Edward H.F. de Haan

      Affiliations

    • Helmholtz Research Institute, Utrecht University, The Netherlands
    • ,
  • L. Jaap Kappelle

      Affiliations

    • Department of Neurology, Rudolf Magnus Institute of Neurosciences, University Medical Center Utrecht, The Netherlands

Received 6 September 2007 ,Accepted 11 October 2007.

References 

  1. Ryan CM. Memory and metabolic control in children. Diabetes Care. 1999;22:1239–1241
  2. Desrocher M, Rovet J. Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol. 2004;10:36–52
  3. Northam EA, Rankins D, Cameron FJ. Therapy insight: the impact of type 1 diabetes on brain development and function. Nat. Clin. Pract. Neurol. 2006;2:78–86
  4. Bryden KS, Peveler RC, Stein A, et al. Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. Diabetes Care. 2001;24:1536–1540
  5. Becker DJ, Ryan CM. Hypoglycemia: a complication of diabetes therapy in children. Trends Endocrinol. Metab. 2000;11:198–202
  6. Northam EA, Anderson PJ, Jacobs R, et al. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care. 2001;24:1541–1546
  7. Ryan C, Vega A, Drash A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics. 1985;75:921–927
  8. Rovet J, Alvarez M. Attentional functioning in children and adolescents with IDDM. Diabetes Care. 1997;20:803–810
  9. Holmes CS, Dunlap WP, Chen RS, Cornwell JM. Gender differences in the learning status of diabetic children. J. Consult Clin. Psychol. 1992;60:698–704
  10. Schoenle EJ, Schoenle D, Molinari L, Largo RH. Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia. 2002;45:108–114
  11. Fox MA, Chen RS, Holmes CS. Gender differences in memory and learning in children with insulin-dependent diabetes mellitus (IDDM) over a 4-year follow-up interval. J. Pediatr. Psychol. 2003;28:569–578
  12. Ryan CM. Why is cognitive dysfunction associated with the development of diabetes early in life? the diathesis hypothesis. Pediatr. Diabetes. 2006;7:289–297
  13. Ferguson SC, Blane A, Wardlaw J, et al. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care. 2005;28:1431–1437
  14. Hershey T, Lillie R, Sadler M, White NH. Severe hypoglycemia and long-term spatial memory in children with type 1 diabetes mellitus: a retrospective study. J. Int. Neuropsychol. Soc. 2003;9:740–750
  15. Hershey T, Bhargava N, Sadler M, et al. Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care. 1999;22:1318–1324
  16. TDCCSG The Diabetes Control and Complications Study Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977–86.
  17. Austin EJ, Deary IJ. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the diabetes control and complications trial data. Diabetes Care. 1999;22:1273–1277
  18. McCarthy AM, Lindgren S, Mengeling MA, et al. Effects of diabetes on learning in children. Pediatrics. 2002;109:E9
  19. Dahlquist G, Kallen B. School performance in children with type 1 diabetes—a population-based register study. Diabetologia. 2007;50:957–964
  20. Brands AMA, Biessels GJ, De Haan EHF, et al. The effects of Type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care. 2005;28:726–735
  21. Brands AM, Kessels RP, Hoogma RP, et al. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes. 2006;55:1800–1806
  22. Jacobson AM, Musen G, Ryan CM, et al. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 2007;356:1842–1852
  23. Ferguson SC, Blane A, Perros P, et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes. 2003;52:149–156
  24. Ryan CM, Geckle MO, Orchard TJ. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia. 2003;46:940–948
  25. Wredling R, Levander S, Adamson U, Lins PE. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia. 1990;33:152–157
  26. Langan SJ, Deary IJ, Hepburn DA, Frier BM. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia. 1991;34:337–344
  27. van Harten B, de Leeuw FE, Weinstein HC, et al. Brain imaging in patients with diabetes: a systematic review. Diabetes Care. 2006;29:2539–2548
  28. Musen G, Lyoo IK, Sparks CR, et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes. 2006;55:326–333
  29. Wessels AM, Simsek S, Remijnse PL, et al. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia. 2006;49:2474–2480
  30. Lobnig BM, Kromeke O, Optenhostert-Porst C, Wolf OT. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications. Diabet. Med. 2006;23:32–39
  31. Wessels AM, Rombouts SA, Remijnse PL, et al. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia. 2007;50:1763–1769
  32. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. Med. 1999;16:93–112
  33. Strachan MWJ, Deary IJ, Ewing FME, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? a critical review of published studies. Diabetes Care. 1997;20:438–445
  34. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J. Clin. Exp. Neuropsychol. 2004;26:1044–1080
  35. Allen KV, Frier BM, Strachan MWJ. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur. J. Pharmacol. 2004;490:169–175
  36. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia. 2005;48:2460–2469
  37. Brands AMA, van den Berg E, Manschot SM, et al. A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. J. Int. Neuropsychol. Soc. 2007;13:288–297
  38. van den Berg E, de Craen AJ, Biessels GJ, et al. The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study. Diabetologia. 2006;49:2015–2023
  39. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607
  40. IDF, International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf) 2005.
  41. Biessels GJ, Kappelle LJ. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?. Biochem. Soc. Trans. 2005;33:1041–1044
  42. Asimakopoulou KG, Hampson SE, Morrish NJ. Neuropsychological functioning in older people with Type 2 diabetes: the effect of controlling for confounding factors. Diabet. Med. 2002;19:311–316
  43. Reaven GM, Thompson LW, Nahum D, Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care. 1990;13:16–21
  44. Manschot SM, Brands AM, van der Grond J, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006;55:1106–1113
  45. Gallacher JE, Pickering J, Elwood PC, et al. Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: data from the Caerphilly study. Eur. J. Epidemiol. 2005;20:761–768
  46. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch. Intern. Med. 2004;164:1327–1333
  47. Ryan CM, Freed MI, Rood JA, et al. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care. 2006;29:345–351
  48. Areosa Sastre A, Grimley Evans V. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst. Rev. 2003;CD003804
  49. Elias PK, Elias MF, D’Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care. 1997;20:1388–1395
  50. Umegaki H, Iimuro S, Kaneko T, et al. Factors associated with lower mini mental state examination scores in elderly Japanese diabetes mellitus patients. Neurobiol. Aging. 2007;
  51. Arvanitakis Z, Wilson RS, Li Y, et al. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care. 2006;29:560–565
  52. Manschot SM, Biessels GJ, de Valk HW, et al. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain MRI in patients with type 2 diabetes. Diabetologia. 2007;50:
  53. Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74
  54. Arvanitakis Z, Schneider JA, Wilson RS, et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006;67:1960–1965
  55. Longstreth WT, Arnold AM, Beauchamp NJ, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2005;36:56–61
  56. Longstreth W-TJ, Arnold AM, Manolio TA, et al. Collaborative Research Group Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Neuroepidemiology. 2000;19:30–42
  57. Vermeer SE, den Heijer T, Koudstaal PJ, et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003;34:392–396
  58. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 2003;348:1215–1222
  59. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology. 2001;56:1539–1545
  60. Launer LJ, Scheltens P, Lindeboom J, et al. Medial temporal lobe atrophy in an open population of very old persons: cognitive, brain atrophy, and sociomedical correlates. Neurology. 1995;45:747–752
  61. Longstreth WT, Bernick C, Manolio TA, et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch. Neurol. 1998;55:1217–1225
  62. Korf ES, White LR, Scheltens P, Launer LJ. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia aging study. Diabetes Care. 2006;29:2268–2274
  63. Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: the Framingham offspring study. Neurology. 2004;63:1591–1599
  64. Jongen C, van der Grond J, Kappelle LJ, et al. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia. 2007;50:1509–1516
  65. van Harten B, Oosterman JM, Potter van Loon BJ, et al. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur. Neurol. 2007;57:70–74

PII: S1751-9918(07)00110-6

doi: 10.1016/j.pcd.2007.10.002

Primary Care Diabetes
Volume 1, Issue 4 , Pages 187-193 , December 2007

Article Tools